← Back to Clinical Trials
Recruiting Phase 3 NCT06140927

Effect of Ketamine on Intraoperative Motor Evoked Potentials

Trial Parameters

Condition Spine Fusion
Sponsor University of California, San Francisco
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2023-12-01
Completion 2026-12-01
Interventions
Ketamine

Brief Summary

The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered increasing doses of ketamine with motor-evoked potentials being measured at each dose, to assess any impacts.

Eligibility Criteria

Inclusion Criteria: * Adult patients (\>18 years of age) undergoing posterior spinal fusions. Exclusion Criteria: * Sensitivity or allergy to ketamine. * Schizophrenia or other psychotic conditions * Uncontrolled hypertension with systolic blood pressure greater than 180 mmHg * Myocardial Infarction * Large vascular aneurysms * Patients on ketamine as outpatient therapy.

Related Trials